Navigation Links
NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
Date:9/26/2007

Company to develop for treatment of neurofibromatosis and cancer

NEW YORK, Sept. 26 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc., a privately held New York biotechnology company focused on developing drugs to treat the genetic disorder neurofibromatosis and related sporadic tumors, today announced that it has entered into a definitive agreement with Universite Louis Pasteur (ULP) and the Centre National de la Recherche Scientifique (CNRS) to in-license a novel family of Hsp90 inhibitors.

"Our preliminary evaluation of these compounds has yielded promising results in NF2 and cancer models", said Dr. Allan Rubenstein, CEO of NexGenix. "While targeting the inhibition of protein folding chaperones such as Hsp90 is an approach that is seeing success in clinical trials for cancer, this target has additionally been shown to be potentially promising for a number of therapeutic indications. We intend to evaluate this compound series for the treatment of several disorders."

Under the terms of this agreement, NexGenix will have an exclusive worldwide license to develop and commercialize the technology for human and animal therapeutic and diagnostic use from ULP and CNRS. NexGenix will be responsible for all development and commercialization costs and activities. In return, ULP and CNRS will be entitled to certain maintenance fees, milestone payments and royalties.

The company has additionally entered into a Collaborative Research Agreement with the Institut de Sciences et d'Ingenierie Supramoleculaires at ULP to further understanding of structure activity relationships and opportunities to improve the pharmacokinetic properties of the in-licensed Hsp90 inhibitor compound series. This research program is to be conducted at ULP by Nicolas Winssinger, PhD. Dr. Winssinger is one of the inventors of the compound series and is a member of the NexGenix Scientific Advisory Board.

About NexGenix Pharmaceuticals

NexGenix Pharmaceu
'/>"/>

SOURCE NexGenix Pharmaceuticals Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. WARF enters licensing agreements for stem cell products
4. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
5. Software company enters health space with RFID solutions on hold
6. Lucigen Corp. enters global licensing agreement
7. Call centers and customer service: The good, the bad, and the clueless
8. GE Healthcare enters agreement with Canadian health authority
9. Data centers: Buyers beware of over-hyped facilities
10. Data centers: Blowing smoke and raising red flags
11. Prodesse enters patent agreement with Roche

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...o,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesCan...ds,adivisionofThompsonsLimitedofBlenheim,Ontario.T...ences,currentseedsbusinessasthecompanyanticipatest...oSciencesHerbicideTolerantTraitTechnologyincornin2.... ,, "Thisacquisitionbringstogethertwostrongpro...
(Date:11/24/2009)... care employment grew by 29,000 jobs in October, ...ent growth during the U.S. recession. However, cli...d health systems are coming closer to having to ac...nistrators. , (Vocus) Nov... growing in October despite the shedding of jobs i...
(Date:11/24/2009)...Newswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX )...mmercializingnovelpainmanagementtherapies,announce...eOfficer,isscheduledtopresentatthe21stAnnualPiperJ...9atTheNewYorkPalaceHotelinNewYork,NewYork. ,, M...,willbeavailabletorespondtoquestionsduringtheprese...
(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...erage technologies for PACS data disaster recovery...anagement (IKM) business unit of Siemens Healthcar...s Corporation ( www.harris.com ) are joining...olutions critical for Picture Archiving and Commun...t business continuity. , , (Logo: http://www...
...Verenium Corporation (Nasdaq: VRNM ), a pioneer ...nzymes and next-generation cellulosic ethanol, tod...ioning of Verenium,s demonstration-scale facility ...t of a commercial joint venture with BP, Verenium ...(R&D) organization, including the pilot and de...
...Pharmaceuticals, Inc. (Nasdaq: AMLN ) today rele...t Director, James N. Wilson, providing shareholder... Fellow Amylin Shareholder: , , As Lead Independe...rovide a summary of exciting business developments...of highly qualified and experienced individuals we...
Other Biology Technology:Siemens Healthcare Announces Planned Collaboration with Harris Corporation 2Siemens Healthcare Announces Planned Collaboration with Harris Corporation 3Siemens Healthcare Announces Planned Collaboration with Harris Corporation 4Verenium Announces Organizational Changes 2Verenium Announces Organizational Changes 3Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 2Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 3Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 4Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 5Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 6Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 7Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 8
(Date:11/23/2009)...edical engineer and cardiologist Tzung "John" Hsia...istinguish cardiac emergencies requiring immediate...gs and lifestyle change. , Angiograms, images ma... the heart, offer an inside view of the interior s...ealing deposits of a dangerous fatty substance cal...
(Date:11/23/2009)..., , , , , , , ,...rew Marshall, from the Environment Department at t... Kinyongia magomberae and his wider work in Tanza...rmation. , , , , , , ... , , , , A new species of chameleon has...
(Date:11/23/2009)...itute for Child Health Research has found evidence... in pregnancy affects child behaviour in different...e in the international journal Addiction . , Le...awn from a random sample of more than 2000 mothers...the baby,s delivery, and were then followed up whe...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3New study links alcohol in pregnancy to child behavior problems 2Finding key to cancer drug Gleevecs limitations 53747 1Finding key to cancer drug Gleevecs limitations 53747 2Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 1Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 2Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 3Joint research into an enzyme that causes genetic diseases 9486 1
...or alcohol has yielded a rapid, inexpensive way to... beat cops keeping misguided cells from attacking ...ers of these cells opens the door to improved trea...eases such as type 1 diabetes and arthritis, Medic... are components of the immune system designed to a...
...in which the enzyme RNA polymerase constructs chai...ds upon previously underappreciated sections of bo...ording to work done with the bacterium E. coli and...a team of bacteriologists from the University of W...ut a key step in RNA synthesis has important impli...
...r bodies are replaced through cell division. Resea... of the puzzle of how genetic information remains ...Their results are presented in the latest issue of...t human consists of about 50,000 billion cells, 1%...ery day. In order to ensure cell survival and cont...
Other Biology News:Finding paves way for better treatment of autoimmune disease 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 3A protein complex that untangles DNA 2
UCB MNC Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
CD8 T Cell Chip-IHC from 3H Biomedical AB
...pecifically for the stabilization of adsorbed or i...oating Stabilizer maintains the conformation and a... of the dried immunoassay components. Product is ...tein-containing stabilizer and blocking solution i...
Biology Products: